DEPO-MEDROL Side Effects

7020796-2 | Abdominal Pain, Decreased Appetite, Lethargy, Weight Decreased
on Sep 22, 2010 Male patient from UNITED KINGDOM , 62 years of age, weighting 209.4 lb, was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), decreased appetite, lethargy, weight decreased. Depo-medrol dosage: 80 Mg, Unk.

7020778-0 | Dyspnoea, Nausea, Ocular Hyperaemia
Patient was taking Depo-medrol (View Usage). Patient had the following side effects: dyspnoea, nausea (What is nausea?), ocular hyperaemia on Sep 22, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 39 years of age, weighting 241.6 lb, was diagnosed with epicondylitis and. Depo-medrol dosage: Unk. During the same period patient was treated with DEPO PROVERA (Unk) (View Depo-provera Review and Depo-provera Label ), IBUPROFEN (400 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ).

7002185-X | Anaphylactic Shock
Adverse event was reported on Sep 16, 2010 by a Female patient taking Depo-medrol (View Usage) (Dosage: Unk) . Location: DENMARK , 28 years of age, After Depo-medrol was administered, patient had the following side effects: anaphylactic shock.

6976238-6 | Abdominal Discomfort, Acne, Blood Pressure Increased, Dizziness, Erythema, Heart Rate Increased, Hunger, Insomnia, Migraine
on Sep 01, 2010 Female patient from UNITED STATES , weighting 175.0 lb, was diagnosed with arthralgia, dyspepsia, hypertension and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, acne (What is acne?), blood pressure increased, dizziness (What is dizziness?), erythema, heart rate increased, hunger, insomnia, migraine (What is migraine?). Depo-medrol dosage: Unk. During the same period patient was treated with PRAVASTATIN SODIUM (Unk) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), ATENOLOL (Unk) (View Atenolol Review and Atenolol Label ).


6958974-0 | Depression, Mania, Mood Altered, Psychotic Disorder
on Aug 24, 2010 Male patient from UNITED KINGDOM , 21 years of age, weighting 176.4 lb, was diagnosed with pain (What is pain?) and was treated with Depo-medrol (View Usage). Patient had the following side effects: depression (What is depression?), mania, mood altered, psychotic disorder (What is psychotic disorder?). Depo-medrol dosage: 40 Mg, Single. During the same period patient was treated with ZOLADEX (1 Df, Every 3 Months) (View Zoladex Review and Zoladex Label ), ESTROGENS (8 Mg, 1x/day) (View Estrogens Review and Estrogens Label ).

6941795-2 | Abdominal Distension, Cataract, Joint Swelling, Muscular Weakness, Vaginal Infection, Vulvovaginal Discomfort, Vulvovaginal Pain
Patient was taking Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: abdominal distension, cataract (What is cataract?), joint swelling, muscular weakness, vaginal infection, vulvovaginal discomfort, vulvovaginal pain on Aug 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, . Depo-medrol dosage: 40 Mg, At 5 Week Intervals.

6918919-6 | Erythema, Fluid Retention, Headache, Pruritus
Adverse event was reported on May 18, 2010 by a Female patient taking Depo-medrol (View Usage) (Dosage: ) . Location: UNITED STATES , 39 years of age, Patient experienced the following unwanted or unexpected effects: erythema, fluid retention, headache (What is headache?), pruritus. During the same period patient was treated with PHENERGAN (View Phenergan Review and Phenergan Label ), TORADOL (View Toradol Review and Toradol Label ), TOCILIZUMAB (ANTI INTERLEUKIN 6) (View Tocilizumab (anti-interleukin 6) Review and Tocilizumab (anti-interleukin 6) Label ).

6918891-9 | Soft Tissue Atrophy
on May 17, 2010 Female patient from UNITED STATES , 33 years of age, weighting 130.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Depo-medrol (View Usage). Patient had the following side effects: soft tissue atrophy. Depo-medrol dosage: 80 Mg, Intra-articular.

6918877-4 | Asthenia, Blood Pressure Increased, Fatigue, Injection Site Swelling, Nausea
on Apr 15, 2010 Female patient from UNITED STATES , 28 years of age, weighting 115.1 lb, was diagnosed with abdominal pain (What is abdominal pain?), nerve injury and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: asthenia, blood pressure increased, fatigue, injection site swelling, nausea (What is nausea?). Depo-medrol dosage: . During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ).

6918808-7 | Blood Glucose Fluctuation, Vitreous Floaters
Patient was taking Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, vitreous floaters on Aug 19, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 134.0 lb, was diagnosed with rotator cuff syndrome, tendonitis and. Depo-medrol dosage: 40 Mg, Single. During the same period patient was treated with PROCAINE (PROCAINE) (View Procaine (procaine) Review and Procaine (procaine) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), INSULIN GLARGINE (INSULIN GLARGINE) (View Insulin Glargine (insulin Glargine) Review and Insulin Glargine (insulin Glargine) Label ), INSULIN LISPRO (INSULIN LISPRO) (View Insulin Lispro (insulin Lispro) Review and Insulin Lispro (insulin Lispro) Label ).

6893217-8 | Anaphylactic Reaction, Asthenia, Dizziness, Hypotension
Adverse event was reported on Jun 22, 2009 by a Female patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , weighting 242.0 lb, Patient had the following side effects: anaphylactic reaction, asthenia, dizziness (What is dizziness?), hypotension. During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ), CRESTOR (View Crestor Review and Crestor Label ), TRICOR (View Tricor Review and Tricor Label ).

6892887-8 | Osteonecrosis
on Nov 06, 2008 Male patient from UNITED STATES , 46 years of age, was diagnosed with intervertebral disc disorder, exostosis and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: osteonecrosis (What is osteonecrosis?). Depo-medrol dosage: .

6892772-1 | Ecchymosis
on Sep 10, 2008 Female patient from UNITED STATES , 61 years of age, weighting 110.2 lb, was diagnosed with pharyngitis and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis. Depo-medrol dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ).

6892754-X | Feeling Abnormal, Hyperhidrosis, Insomnia, Vision Blurred
Patient was taking Depo-medrol (View Usage). Patient had the following side effects: feeling abnormal, hyperhidrosis, insomnia, vision blurred on Sep 05, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 215.0 lb, was diagnosed with headache (What is headache?) and. Depo-medrol dosage: . During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ).

6892596-5 | Burning Sensation, Pain, Swelling
Adverse event was reported on Jul 15, 2008 by a Female patient taking Depo-medrol (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 197.0 lb, After Depo-medrol was administered, patient had the following side effects: burning sensation, pain (What is pain?), swelling. During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ).

6892581-3 | Mobility Decreased
on Jul 08, 2008 Female patient from UNITED STATES , weighting 133.0 lb, was diagnosed with arthropathy and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: mobility decreased. Depo-medrol dosage: . During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ).

6892459-5 | Back Pain, Headache
on May 16, 2008 Female patient from UNITED STATES , weighting 96.20 lb, was diagnosed with neck pain, musculoskeletal pain, agoraphobia and was treated with Depo-medrol (View Usage). Patient had the following side effects: back pain (What is back pain?), headache (What is headache?). Depo-medrol dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DARVOCET (View Darvocet Review and Darvocet Label ).

6892338-3 | Product Quality Issue
Patient was taking Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: product quality issue on Apr 04, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 155.3 lb, . Depo-medrol dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ).

6892227-4 | Anaphylactic Reaction
Adverse event was reported on May 16, 2008 by a Female patient taking Depo-medrol (View Usage) (Dosage: 40 Mg) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. During the same period patient was treated with ULTRAM (View Ultram Review and Ultram Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), SKELAXIN (View Skelaxin Review and Skelaxin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6892194-3 | Blood Glucose Increased, Blood Test Abnormal, Neutrophil Count Increased
on Mar 10, 2008 Female patient from UNITED STATES , weighting 192.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Depo-medrol (View Usage). Patient had the following side effects: blood glucose increased, blood test abnormal, neutrophil count increased. Depo-medrol dosage: . During the same period patient was treated with DARVOCET (View Darvocet Review and Darvocet Label ), CELEBREX (View Celebrex Review and Celebrex Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), DUONEB (View Duoneb Review and Duoneb Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6891975-X | No Adverse Event
on Nov 30, 2007 Male patient from UNITED STATES , weighting 113.0 lb, was diagnosed with spinal cord injury and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: no adverse event. Depo-medrol dosage: .

6891959-1 | No Adverse Event
Patient was taking Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event on Dec 05, 2007 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 190.0 lb, was diagnosed with hypersensitivity, dysphagia and. Depo-medrol dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), NEXIUM (View Nexium Review and Nexium Label ), DECONGESTANT (View Decongestant Review and Decongestant Label ).

6891757-9 | Injection Site Erythema, Injection Site Warmth
Adverse event was reported on Oct 03, 2007 by a Male patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with dyspnoea, asthma (What is asthma?), chronic obstructive pulmonary disease and. Location: UNITED STATES , 52 years of age, weighting 172.0 lb, Patient had the following side effects: injection site erythema, injection site warmth. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), PEPCID (View Pepcid Review and Pepcid Label ), LASIX (View Lasix Review and Lasix Label ), QUESTRAN (View Questran Review and Questran Label ), COREG (View Coreg Review and Coreg Label ).

6891553-2 | Urticaria
on May 13, 2004 Female patient from UNITED STATES , 91 years of age, was diagnosed with asthma (What is asthma?) and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: urticaria. Depo-medrol dosage: .

6891535-0 | Scar, Skin Disorder
on Dec 01, 2007 Female patient from UNITED STATES , 56 years of age, was diagnosed with epicondylitis and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: scar (What is scar?), skin disorder. Depo-medrol dosage: . During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ).

6891528-3 | Arthralgia, Back Pain, Cartilage Injury, Gait Disturbance, Osteonecrosis
Patient was taking Depo-medrol (View Usage). Patient had the following side effects: arthralgia, back pain (What is back pain?), cartilage injury, gait disturbance, osteonecrosis (What is osteonecrosis?) on Dec 13, 2007 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 149.9 lb, was diagnosed with sciatica (What is sciatica?), back pain (What is back pain?) and. Depo-medrol dosage: .

6891488-5 | Injection Site Reaction
Adverse event was reported on Jul 16, 2007 by a Female patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with ear infection (What is ear infection?), contraception and. Location: UNITED STATES , weighting 129.3 lb, After Depo-medrol was administered, patient had the following side effects: injection site reaction. During the same period patient was treated with YASMIN (View Yasmin Review and Yasmin Label ).

6891467-8 | Blood Cholesterol Increased
on Jul 30, 2007 Female patient from UNITED STATES , 40 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased. Depo-medrol dosage: Every Three Months.

6891400-9 | Amnesia, Neck Pain
on Jun 12, 2006 Female patient from UNITED STATES , weighting 174.0 lb, was diagnosed with surgery (What is surgery?), compression fracture and was treated with Depo-medrol (View Usage). Patient had the following side effects: amnesia, neck pain. Depo-medrol dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), ZETIA (View Zetia Review and Zetia Label ), IMDUR (View Imdur Review and Imdur Label ), TRIMPEX (View Trimpex Review and Trimpex Label ), PEPCID (View Pepcid Review and Pepcid Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6891393-4 | Urticaria
Patient was taking Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: urticaria on Dec 01, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with hypersensitivity and. Depo-medrol dosage: . During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6891381-8 | Anxiety, Depressed Mood, Euphoric Mood, Eye Pain, Headache, Hyperhidrosis, Mood Swings, Sedation
Adverse event was reported on Mar 16, 2007 by a Male patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with arthralgia, depression (What is depression?) and. Location: UNITED STATES , weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), depressed mood, euphoric mood, eye pain, headache (What is headache?), hyperhidrosis, mood swings, sedation. During the same period patient was treated with NARDIL (View Nardil Review and Nardil Label ), VALIUM (View Valium Review and Valium Label ), ATIVAN (View Ativan Review and Ativan Label ).

6891377-6 | Photosensitivity Reaction, Rash, Sunburn
on Apr 24, 2007 Male patient from UNITED STATES , 45 years of age, was diagnosed with arthralgia and was treated with Depo-medrol (View Usage). Patient had the following side effects: photosensitivity reaction, rash (What is rash?), sunburn. Depo-medrol dosage: .

6891376-4 | Swelling Face
on Jun 28, 2006 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with dermatitis contact, depression (What is depression?), attention deficit/hyperactivity disorder, narcolepsy, thyroid operation, osteoarthritis (What is osteoarthritis?) and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: swelling face. Depo-medrol dosage: . During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PROVIGIL (View Provigil Review and Provigil Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6891374-0 | Increased Appetite
Patient was taking Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: increased appetite on Jun 16, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with back pain (What is back pain?) and. Depo-medrol dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ).

6891371-5 | No Adverse Event
Adverse event was reported on Feb 04, 2007 by a Male patient taking Depo-medrol (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 118.0 lb, Patient had the following side effects: no adverse event.

6891367-3 | Insomnia
on Aug 17, 2006 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with sinus disorder and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: insomnia. Depo-medrol dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6891362-4 | No Adverse Event
on Apr 05, 2007 Male patient from UNITED STATES , 71 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Depo-medrol dosage: .

6891359-4 | Blood Glucose Increased
Patient was taking Depo-medrol (View Usage). Patient had the following side effects: blood glucose increased on Oct 25, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 210.0 lb, was diagnosed with dermatitis contact and. Depo-medrol dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6891357-0 | Flushing
Adverse event was reported on Aug 31, 2006 by a Male patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with pharyngeal oedema and. Location: UNITED STATES , 23 years of age, After Depo-medrol was administered, patient had the following side effects: flushing. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

6879189-0 | Cytomegalovirus Chorioretinitis, Visual Acuity Reduced
on Jul 22, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with retinal vasculitis, mixed connective tissue disease and was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus chorioretinitis, visual acuity reduced. Depo-medrol dosage: 40 Mg, 1x/day. During the same period patient was treated with CYCLOPHOSPHAMIDE (100 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized and became disabled.

6871244-4 | Abdominal Distension, Cataract, Joint Swelling, Muscular Weakness, Vaginal Infection, Vulvovaginal Discomfort, Vulvovaginal Pain
on Jul 14, 2010 Female patient from UNITED KINGDOM , 70 years of age, was treated with Depo-medrol (View Usage). Patient had the following side effects: abdominal distension, cataract (What is cataract?), joint swelling, muscular weakness, vaginal infection, vulvovaginal discomfort, vulvovaginal pain. Depo-medrol dosage: 40 Mg, At 5 Week Intervals.

6862996-8 | Depression, Mania, Psychotic Disorder
Patient was taking Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: depression (What is depression?), mania, psychotic disorder (What is psychotic disorder?) on Jul 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 22 years of age, . Depo-medrol dosage: 40 Mg, Unk. During the same period patient was treated with ZOLADEX (Unk) (View Zoladex Review and Zoladex Label ).

6841608-3 | Cytomegalovirus Chorioretinitis, Visual Acuity Reduced
Adverse event was reported on Jun 30, 2010 by a Female patient taking Depo-medrol (View Usage) (Dosage: 100 Unk, Unk) was diagnosed with retinal vasculitis, mixed connective tissue disease and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: cytomegalovirus chorioretinitis, visual acuity reduced. During the same period patient was treated with CYCLOPHOSPHAMIDE (100 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized and became disabled.

6839604-5 | Tenosynovitis
on Jul 07, 2010 Female patient from JAPAN , 33 years of age, was treated with Depo-medrol (View Usage). Patient had the following side effects: tenosynovitis. Depo-medrol dosage: Unk.

6800819-3 | Cytomegalovirus Chorioretinitis, Visual Acuity Reduced
on Jun 17, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with retinal vasculitis, mixed connective tissue disease and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: cytomegalovirus chorioretinitis, visual acuity reduced. Depo-medrol dosage: 100 Unk, Unk. During the same period patient was treated with ENDOXAN (100 Mg/day) (View Endoxan Review and Endoxan Label ).

6787909-9 | Metrorrhagia
Patient was taking Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: metrorrhagia on Oct 29, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 138.9 lb, was diagnosed with stomatitis, vaginitis bacterial and. Depo-medrol dosage: . During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), VALTREX (View Valtrex Review and Valtrex Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6785207-0 | Arthralgia, Arthritis, Aspiration Joint Abnormal, Cold Sweat, Gait Disturbance, Joint Stiffness, Oedema Peripheral, Skin Discolouration
Adverse event was reported on Jun 22, 2010 by a Male patient taking Depo-medrol (View Usage) (Dosage: ) was diagnosed with meniscus lesion and. Location: UNITED STATES , weighting 210.0 lb, Patient had the following side effects: arthralgia, arthritis (What is arthritis?), aspiration joint abnormal, cold sweat, gait disturbance, joint stiffness, oedema peripheral, skin discolouration. During the same period patient was treated with LIDOCAINE HCI 1% HOSPIRA (View Lidocaine Hci 1% Hospira Review and Lidocaine Hci 1% Hospira Label ), MARCAINE (View Marcaine Review and Marcaine Label ).

6781491-8 | Cytomegalovirus Chorioretinitis, Visual Acuity Reduced
on Jun 09, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with retinal vasculitis, mixed connective tissue disease and was treated with Depo-medrol (View Usage). After Depo-medrol was administered, patient had the following side effects: cytomegalovirus chorioretinitis, visual acuity reduced. Depo-medrol dosage: 100 Unk, Unk. During the same period patient was treated with ENDOXAN (100 Mg/day) (View Endoxan Review and Endoxan Label ).

6760602-4 | Abdominal Distension, Cataract, Infection, Muscular Weakness, Vulvovaginal Pain
on Jun 01, 2010 Female patient from UNITED KINGDOM , 70 years of age, was treated with Depo-medrol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, cataract (What is cataract?), infection (What is infection?), muscular weakness, vulvovaginal pain. Depo-medrol dosage: 40 Mg, At 5 Week Intervals.

6753202-3 | Altered State Of Consciousness, Blood Pressure Decreased, Heart Rate Increased, Hypersensitivity, Muscle Spasms, Nausea, Oxygen Saturation Decreased, Rash
Patient was taking Depo-medrol (View Usage). Patient had the following side effects: altered state of consciousness, blood pressure decreased, heart rate increased, hypersensitivity, muscle spasms, nausea (What is nausea?), oxygen saturation decreased, rash (What is rash?) on May 25, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 76 years of age, weighting 167.6 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Depo-medrol dosage: 80 Mg, 1x/day. During the same period patient was treated with MARCAINE (10 Ml, 1x/day) (View Marcaine Review and Marcaine Label ), CELEBREX (100 Mg, 1x/day) (View Celebrex Review and Celebrex Label ), LEVOTHYROXINE (100 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), PARACETAMOL (500mg To 1g, Qid, As Needed) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.